Skip to main content
    N

    Nuvation Bio Inc (NUVB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NYSE

    $3.86
    -0.13 (-3.26%)

    Market Cap: $1.41B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Nuvation Bio Inc (NUVB) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Nuvation Bio are Nuvectis Pharma (NVCT), Nektar Therapeutics (NKTR) and Nurix Therapeutics (NRIX). By market cap, Nuvation Bio ranks 7th of the 13 companies on this page; Biohaven (BHVN) is the largest at $2.09B.

    Peer Comparison

    NUVB's ROIC of -18.7% is above the peer median of -66.6%, and its revenue growth of 242.6% is above the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Nuvation Bio (NUVB)$1.41BN/A6.7x-67.4%-18.7%242.6%0.00%
    Nuvectis Pharma Inc (NVCT)$696.03MN/AN/A0.0%N/A0.0%0.00%
    Nektar Therapeutics (NKTR)$1.27BN/A23.9x0.0%N/A-20.4%0.00%
    Nurix Therapeutics Inc (NRIX)$1.69B6.4x2.3x42.0%N/A8426.0%0.00%
    Novavax Inc (NVAX)$1.41BN/A3.2x-18.6%-66.6%-3.0%0.00%
    Vir Biotechnology Inc (VIR)$1.71BN/A5.4x-61.0%N/A19582.0%0.00%
    Innoviva Inc (INVA)$1.35B5.3x3.0x44.1%10.8%-1.6%0.00%
    Ultragenyx (RARE)$1.64BN/A2.2x-71.8%N/A8.1%0.00%
    Zenas BioPharma, Inc. Common Stock (ZBIO)$1.90BN/A168.0x0.0%-104.3%-100.0%0.00%
    Biohaven Ltd. (BHVN)$2.09BN/AN/A0.0%-315.9%0.0%0.00%
    Vor Biopharma Inc (VOR)$1.19BN/AN/A0.0%N/A0.0%0.00%
    Uniqure NV (QURE)$1.67BN/A75.8x0.0%-57.9%40.4%0.00%
    Tyra Biosciences Inc (TYRA)$1.38BN/AN/A0.0%N/A0.0%0.00%
    Peer median$1.52B5.8x4.3x0.0%-66.6%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Nuvation Bio, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Nuvectis Pharma Inc (NVCT)
    Nuvectis Pharma, Inc., a biopharmaceutical company, is focused on the development of targeted small molecule therapies for the treatment of cancer.
    NVCT competitors
    Nektar Therapeutics (NKTR)
    Nektar Therapeutics is a biopharmaceutical company.
    NKTR competitors
    Nurix Therapeutics Inc (NRIX)
    Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development...
    NRIX competitors
    Novavax Inc (NVAX)
    Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases...
    NVAX competitors
    Vir Biotechnology Inc (VIR)
    Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.
    VIR competitors
    Innoviva Inc (INVA)
    Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.
    INVA competitors
    Ultragenyx (RARE)
    Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development...
    RARE competitors
    Zenas BioPharma, Inc. Common Stock (ZBIO)
    Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based...
    ZBIO competitors
    Biohaven Ltd. (BHVN)
    Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops candidate products targeting neurological diseases and rare disorders...
    BHVN competitors
    Vor Biopharma Inc (VOR)
    Vor Biopharma, Inc., an early stage cell therapy company, develops hematopoietic stem cell (eHSC) therapies designed for cancer patients.
    VOR competitors
    Uniqure NV (QURE)
    uniQure NV, a gene therapy company, is dedicated to developing treatments for patients suffering from genetic and other devastating diseases.
    QURE competitors
    Tyra Biosciences Inc (TYRA)
    Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and improve outcomes...
    TYRA competitors

    Frequently Asked Questions About NUVB

    Who are Nuvation Bio's main competitors?

    The companies most similar to Nuvation Bio include Nuvectis Pharma (NVCT), Nektar Therapeutics (NKTR), Nurix Therapeutics (NRIX), Novavax (NVAX) and Vir Biotechnology (VIR), listed from the closest match.

    Who is Nuvation Bio's biggest competitor?

    Biohaven (BHVN) is the largest of the similar companies at $2.09B; Nuvectis Pharma (NVCT) is the closest match by business profile, size, sector and industry.

    How does NUVB stock compare with its competitors?

    NUVB's P/S is 6.7x against a peer median of 4.3x; its net margin is -67.4% against a peer median of 0.0%.

    Which of Nuvation Bio's competitors pays a higher dividend?

    Nuvation Bio pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Nuvation Bio bigger than its competitors?

    No. Nuvation Bio is 7th by market cap among the 13 companies on this page; the largest is Biohaven (BHVN) at $2.09B.